Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,159 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Twelve weeks posttreatment follow-up is as relevant as 24 weeks to determine the sustained virologic response in patients with hepatitis C virus receiving pegylated interferon and ribavirin.
Martinot-Peignoux M, Stern C, Maylin S, Ripault MP, Boyer N, Leclere L, Castelnau C, Giuily N, El Ray A, Cardoso AC, Moucari R, Asselah T, Marcellin P. Martinot-Peignoux M, et al. Among authors: stern c. Hepatology. 2010 Apr;51(4):1122-6. doi: 10.1002/hep.23444. Hepatology. 2010. PMID: 20069649
Direct comparison of diagnostic performance of transient elastography in patients with chronic hepatitis B and chronic hepatitis C.
Cardoso AC, Carvalho-Filho RJ, Stern C, Dipumpo A, Giuily N, Ripault MP, Asselah T, Boyer N, Lada O, Castelnau C, Martinot-Peignoux M, Valla DC, Bedossa P, Marcellin P. Cardoso AC, et al. Among authors: stern c. Liver Int. 2012 Apr;32(4):612-21. doi: 10.1111/j.1478-3231.2011.02660.x. Epub 2011 Nov 22. Liver Int. 2012. PMID: 22103765 Clinical Trial.
Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year, Prospective, Real-World Study in France.
Marcellin P, Zoulim F, Hézode C, Causse X, Roche B, Truchi R, Pauwels A, Ouzan D, Dumortier J, Pageaux GP, Bourlière M, Riachi G, Zarski JP, Cadranel JF, Tilliet V, Stern C, Pétour P, Libert O, Consoli SM, Larrey D. Marcellin P, et al. Among authors: stern c. Dig Dis Sci. 2016 Oct;61(10):3072-3083. doi: 10.1007/s10620-015-4027-8. Epub 2016 Jan 28. Dig Dis Sci. 2016. PMID: 26821154 Free PMC article.
Treatment with bulevirtide in HIV-infected patients with chronic hepatitis D: ANRS HD EP01 BuleDelta and compassionate cohort.
de Lédinghen V, Fougerou-Leurent C, Le Pabic E, Pol S, Alfaiate D, Lacombe K, Hilleret MN, Lascoux-Combe C, Minello A, Billaud E, Rosa I, Gervais A, Ratziu V, Ganne N, Pageaux GP, Leroy V, Loustaud-Ratti V, Mathurin P, Chas J, Jezequel C, Métivier S, Dumortier J, Arpurt JP, Asselah T, Roche B, Le Gruyer A, Valantin MA, Scholtès C, Gordien E, Tual C, Kortebi A, Coulibaly F, Rosenthal E, Subic-Levrero M, Roulot D, Zoulim F; ANRS HD EP01 BuleDelta study group. de Lédinghen V, et al. JHEP Rep. 2024 Mar 26;6(8):101057. doi: 10.1016/j.jhepr.2024.101057. eCollection 2024 Aug. JHEP Rep. 2024. PMID: 39045338 Free PMC article.
High Diagnostic Value of Transient Elastography for Advanced Fibrosis and Cirrhosis in Patients With Chronic Hepatitis Delta.
Roulot D, Brichler S, Layese R, D'alteroche L, Ganne-Carrie N, Stern C, Saviano A, Leroy V, Roudot-Thoraval F, De Ledinghen V; DELTAVIR study group. Roulot D, et al. Among authors: stern c. Clin Gastroenterol Hepatol. 2024 Aug 30:S1542-3565(24)00776-6. doi: 10.1016/j.cgh.2024.08.008. Online ahead of print. Clin Gastroenterol Hepatol. 2024. PMID: 39209196
Non-invasive diagnosis of hepatic steatosis.
Stern C, Castera L. Stern C, et al. Hepatol Int. 2017 Jan;11(1):70-78. doi: 10.1007/s12072-016-9772-z. Epub 2016 Oct 25. Hepatol Int. 2017. PMID: 27783208 Review.
1,159 results